Maximal S.D. | ED501-a | 95% CL | Dose Ratio vs. Control1-b | 95% CL | Dose Ratio vs. 20 MS1-c | 95% CL | |
---|---|---|---|---|---|---|---|
Stimulus effects | |||||||
+ 10 C-Cam (n = 5) | |||||||
Control | 100 | 0.99 | 0.52–1.9 | ||||
10 mg/kg C-Cam | 100 | 6.41-150 | 2.6–16 | 6.5 | 2.7–15 | ||
Chronic MS + 3.2 C-Cam (n = 7) | |||||||
Control | 100 | 0.58 | 0.40–0.85 | ||||
20 mg/kg per day MS | 100 | 1.41-150 | 0.84–2.3 | 2.4 | 1.6–3.5 | ||
3.2 mg/kg C-Cam | 91 | 101-150 1-151 | 4.1–25 | 18 | 6.8–45 | 7.3 | 3.7–14 |
Recovery, week 1 | 95 | 2.31-150 | 0.97–5.5 | 4.0 | 1.8–8.8 | 1.7 | 0.93–2.9 |
Recovery, week 2 | 93 | 1.31-150 | 0.63–2.8 | 2.3 | 0.98–5.4 | 0.96 | 0.50–1.8 |
Chronic MS + 10 C-Cam (n = 6) | |||||||
Control | 98 | 0.56 | 0.31–1.0 | ||||
20 mg/kg per day MS | 99 | 1.91-150 | 1.2–3.0 | 3.4 | 2.4–4.8 | ||
10 mg/kg C-Cam | 86 | 121-150 1-151 1-d | 4.9–32 | 22 | 9.0–54 | 6.5 | 2.9–15 |
Recovery, week 1 | 86 | 1.1 | 0.078–16 | 2.0 | 0.12–31 | 0.58 | 0.034–9.9 |
Recovery, week 2 | 100 | 0.68 | 0.31–1.5 | 1.2 | 0.50–2.9 | 0.36 | 0.14–0.95 |
Rate effects | |||||||
+ 10 C-Cam | |||||||
Control | 2.8 | 1.3–6.2 | |||||
10 mg/kg C-Cam | 181-150 | 10–34 | 6.5 | 3.3–13 | |||
Chronic MS + 3.2 C-Cam | |||||||
Control | 3.3 | 2.6–4.0 | |||||
20 mg/kg per day MS | 6.11-150 | 4.4–8.2 | 1.9 | 1.4–2.4 | |||
3.2 mg/kg C-Cam | 351-150 1-151 | 24–52 | 11 | 8.6–14 | 5.8 | 4.3–7.9 | |
Recovery, week 1 | 9.31-150 1-151 | 6.8–13 | 2.8 | 2.1–3.8 | 1.5 | 1.2–2.0 | |
Recovery, week 2 | 4.01-151 | 3.3–4.9 | 1.2 | 0.99–1.5 | 0.67 | 0.58–0.77 | |
Chronic MS + 10 C-Cam | |||||||
Control | 2.3 | 1.2–4.3 | |||||
20 mg/kg per day MS | 4.1 | 2.8–6.1 | 1.8 | 0.95–3.4 | |||
10 mg/kg C-Cam | 771-150 1-151 | 41–145 | 34 | 17–65 | 19 | 9.8–36 | |
Recovery, week 1 | 201-150 1-151 | 12–36 | 8.9 | 4.4–18 | 5.0 | 2.8–8.6 | |
Recovery, week 2 | 4.5 | 3.0–6.6 | 1.9 | 1.2–3.1 | 1.1 | 0.67–1.8 |
Clocinnamox treatment was administered alone or during treatment with doses of 20 mg/kg per day morphine.
↵1-150 Significantly different from control ED50,P < 0.05.
↵1-151 Significantly different from ED50 during treatment with 20 mg/kg per day morphine, P < 0.05.
↵1-a All non-linear regressions of stimulus effects or response rate on log10 dose were statistically significant,P < 0.05. Unless noted, slopes of test curves did not differ from slopes of control curves.
↵1-b Ratio expressed as (ED50 after treatment / ED50 for control curve).
↵1-c Ratio expressed as (ED50 after treatment / ED50 following MS treatment).
↵1-d Slope differs from those of control curve and curve during treatment with 20 mg/kg per day morphine.